Moogene Medi Co Ltd
322970
Company Profile
Business description
Moogene Medi Co Ltd is a bio-technology company engaged in gene therapy and nano-materials fabrication using cutting-edge nanotechnologies. The company has developed programs to monitor KRAS-mutant cancer strains, androgenic alopecia, type two diabetes, and liver diseases.
Contact
670, Daewangpangyo-ro, Bundang-gu
U-space 2 A-505
Gyeonggi-do
Seongnam-si
KORT: +82 316286886
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
18
Stocks News & Analysis
stocks
Unconventional wisdom: Are dividends the answers?
As investors toil in complexity the obvious solution may be the right one.
stocks
Netflix: A business that’s nearly flawless
Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks
Trump’s US dollar assault is fuelling CBA’s rise
A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,934.30 | 45.10 | -0.50% |
| CAC 40 | 7,808.88 | 9.40 | -0.12% |
| DAX 40 | 24,123.34 | 172.59 | -0.71% |
| Dow JONES (US) | 44,693.91 | 316.38 | -0.70% |
| FTSE 100 | 9,106.76 | 31.61 | -0.35% |
| HKSE | 25,388.35 | 278.83 | -1.09% |
| NASDAQ | 21,057.96 | 37.94 | 0.18% |
| Nikkei 225 | 41,456.23 | 370.11 | -0.88% |
| NZX 50 Index | 12,853.46 | 48.33 | 0.38% |
| S&P 500 | 6,363.35 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,666.90 | 42.50 | -0.49% |
| SSE Composite Index | 3,593.66 | 12.07 | -0.33% |